Organization: Institute for Health Policy Management and Evaluation (IHPME)

Vaccine independence requires a 21st-Century Connaught Labs, policy experts argue

The federal and Ontario governments recently announced a $470-million investment to expand Sanofi Pasteur Limited’s vaccine manufacturing capability. But for Canada to be truly self-sufficient in vaccine development and production, critics say other models must be considered—including a 21st-century version of Connaught Labs.